Our findings are also consistent with recent Western blotting approaches describing a significant decrease in the protein expression of GluA1 and GluA2 in the hippocampus of AD patients [20] and with previous autoradiographic studies indicating that the binding of glutamate to AMPARs was significantly decreased, particularly in the CA1 region [38,39,40]. Here, GRIA2 is linked to Alzheimer disease.